Order by 3pm for delivery before the Bank Holiday. Orders placed after 3pm will be processed from Tuesday.
£69.99
481 in stock
For research use only — Not for human or animal use
SLU-PP-332 250mcg is a high-quality research compound developed for laboratory studies investigating cellular energy metabolism, mitochondrial function and estrogen-related receptor (ERR) signalling.
SLU-PP-332 is a synthetic small molecule rather than a peptide. It acts as an agonist of the ERRα, ERRβ and ERRγ receptors, which are involved in regulating genes associated with energy production and oxidative metabolism.
This mechanism has generated significant research interest because activation of these pathways can reproduce certain molecular responses associated with aerobic exercise in preclinical experimental models.
SLU-PP-332 is an experimental compound commonly described in scientific literature as a pan-ERR agonist.
Estrogen-related receptors are nuclear receptors that help control how cells use and produce energy. Despite their name, these receptors are distinct from conventional estrogen receptors and do not simply function as estrogen receptors.
Researchers are particularly interested in ERRα because of its involvement in mitochondrial activity, oxidative metabolism and the physiological response to exercise.
SLU-PP-332 remains an experimental research compound, but preclinical studies have made it particularly interesting for investigations involving:
These are areas of laboratory investigation rather than established benefits in humans.
Put simply, researchers are studying SLU-PP-332 because it can activate some of the cellular pathways that normally become more active during exercise.
Cells contain mitochondria, which can be thought of as their energy-producing machinery. SLU-PP-332 research looks at whether activating ERR receptors can encourage cells and tissues to become better at producing and using energy.
In animal studies, researchers have investigated changes involving energy expenditure, endurance, fat metabolism and mitochondrial activity.
This is why SLU-PP-332 is sometimes referred to as an “exercise mimetic” in research. This term does not mean it is a replacement for exercise; it describes its ability to reproduce certain molecular signals associated with exercise in experimental models.
Mitochondria convert nutrients into usable cellular energy. Their function is therefore closely connected with metabolism, skeletal muscle activity and endurance.
ERR receptors play an important role in controlling genes involved in mitochondrial energy production. By activating these receptors, SLU-PP-332 provides researchers with a useful way of studying how changes to ERR signalling influence mitochondrial and metabolic processes.
This makes the compound particularly relevant to laboratory research examining the relationship between cellular energy production and physical performance.
Another important area of investigation involves metabolic function. Preclinical studies have explored whether ERR activation can alter the way experimental models process and utilise nutrients. Researchers have reported changes in pathways associated with fatty-acid oxidation, energy expenditure and oxidative metabolism.
These findings have contributed to wider scientific interest in ERR agonists for understanding metabolic regulation. Importantly, results observed in laboratory and animal models cannot be assumed to produce the same effects in humans.
No. Although SLU-PP-332 is frequently discussed alongside research peptides, it is chemically different. SLU-PP-332 is a synthetic small molecule with a molecular weight of approximately 290.32 g/mol.
This distinction is important when designing experiments because its chemical properties, solubility and laboratory handling requirements differ from lyophilised peptide products.
SLU-PP-332 is an experimental compound and does not have an established human side-effect profile.
Research to date has primarily involved laboratory and animal models. Consequently, it would be inaccurate to present a definitive list of human side effects or describe SLU-PP-332 as proven safe.
Researchers should use appropriate laboratory risk-management procedures and consult the relevant Safety Data Sheet before handling the material.
High-quality research materials are important when studying compounds such as SLU-PP-332 because concentration, identity and chemical purity can directly influence experimental reproducibility.
SLU-PP-332 is suitable for controlled laboratory investigations involving:
“`html
| Specification | Details |
|---|---|
| Product Name | SLU-PP-332 |
| Product Type | Synthetic small-molecule research compound |
| Dosage Form | Capsules |
| Strength | 250 mcg per capsule |
| Chemical Name | (E)-4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide |
| Alternative Name | SR9861 |
| Molecular Formula | C18H14N2O2 |
| Molecular Weight | 290.32 g/mol |
| CAS Number | 303760-60-3 |
| Primary Research Target | ERRα, ERRβ and ERRγ |
| Compound Class | Pan-estrogen-related receptor agonist |
| Presentation | Pre-measured capsule format |
| Storage | Store in a cool, dry place away from direct light and moisture; follow product-specific COA/SDS guidance |
| Intended Use | Laboratory research only |
Discount Applied Successfully!
Your savings have been added to the cart.
